ZA92234B - Novel steroid esters - Google Patents

Novel steroid esters

Info

Publication number
ZA92234B
ZA92234B ZA92234A ZA92234A ZA92234B ZA 92234 B ZA92234 B ZA 92234B ZA 92234 A ZA92234 A ZA 92234A ZA 92234 A ZA92234 A ZA 92234A ZA 92234 B ZA92234 B ZA 92234B
Authority
ZA
South Africa
Prior art keywords
novel steroid
steroid esters
esters
novel
steroid
Prior art date
Application number
ZA92234A
Other languages
English (en)
Inventor
Bengt Ingemar Axelsson
Ralph Lennart Brattsand
Leif Arne Kaellstroem
Arne Bror Thalen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA92234B publication Critical patent/ZA92234B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA92234A 1991-02-04 1992-01-13 Novel steroid esters ZA92234B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100342A SE9100342D0 (sv) 1991-02-04 1991-02-04 Novel steroid esters

Publications (1)

Publication Number Publication Date
ZA92234B true ZA92234B (en) 1992-10-28

Family

ID=20381807

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92234A ZA92234B (en) 1991-02-04 1992-01-13 Novel steroid esters

Country Status (38)

Country Link
US (1) US5614514A (bg)
EP (1) EP0572451B1 (bg)
JP (1) JP2947933B2 (bg)
KR (1) KR100205835B1 (bg)
CN (3) CN1039329C (bg)
AP (1) AP365A (bg)
AT (1) ATE164589T1 (bg)
BG (1) BG61816B1 (bg)
CA (1) CA2100453A1 (bg)
CZ (1) CZ282057B6 (bg)
DE (1) DE69224982T2 (bg)
DK (1) DK0572451T3 (bg)
DZ (1) DZ1554A1 (bg)
EE (1) EE03110B1 (bg)
ES (1) ES2114931T3 (bg)
FI (1) FI933451A (bg)
HK (1) HK1004335A1 (bg)
HU (1) HU221168B1 (bg)
IE (1) IE920167A1 (bg)
IL (1) IL100542A (bg)
IS (1) IS1653B (bg)
MA (1) MA22407A1 (bg)
MX (1) MX9200374A (bg)
MY (1) MY111502A (bg)
NO (1) NO304074B1 (bg)
NZ (1) NZ241211A (bg)
PL (1) PL170383B1 (bg)
PT (1) PT100087B (bg)
RO (1) RO111272B1 (bg)
RU (1) RU2112775C1 (bg)
SE (1) SE9100342D0 (bg)
SK (1) SK281802B6 (bg)
TN (1) TNSN92008A1 (bg)
TW (1) TW287166B (bg)
UA (1) UA43825C2 (bg)
WO (1) WO1992013873A1 (bg)
YU (1) YU48893B (bg)
ZA (1) ZA92234B (bg)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
KR960700266A (ko) * 1993-01-08 1996-01-19 클래스 빌헬름슨 신규 결장- 또는 회장-특이성 스테로이드 유도체(Novel Colon-or lleum-Specific Steroid Derivatives)
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
ES2341532T3 (es) 1999-05-27 2010-06-22 Euro-Celtique S.A. Preparacion con povidona yodada para el tratamiento de heridas.
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
AU2003217535A1 (en) * 2002-02-20 2003-09-09 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
US20050009798A1 (en) 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
EP1521764A2 (en) 2002-07-08 2005-04-13 PLIVA-ISTRAZIVACKI INSTITUT d.o.o. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
ES2325495T3 (es) 2002-07-08 2009-09-07 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Moleculas hibridas de macrolidos con moleculas anti-inflamatorias esteroideas y no esteroideas.
US20040157810A1 (en) * 2002-08-23 2004-08-12 Teicher Martin H. Corticosteroid conjugates and uses thereof
WO2004033478A2 (en) * 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
WO2005016352A1 (en) * 2003-08-05 2005-02-24 Sepracor Inc. AMINO ACID AND PEPTIDE-MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH ß2 ADRENERGIC AGONISTS
KR20070083811A (ko) 2004-10-27 2007-08-24 글락소스미쓰클라인 이스트라지바치키 센타 자그레브 디.오.오. 항-염증 활성을 가진 접합체
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US8737506B1 (en) 2010-12-29 2014-05-27 Sprint Communications Company L.P. Determination of transmit diversity transmission delays
US8437713B1 (en) 2011-02-16 2013-05-07 Sprint Communications Company L.P. Wireless transmit diversity control by location of a wireless communication device
US8565686B2 (en) 2011-06-30 2013-10-22 Sprint Communications Company L.P. Power status multipath search window sizing for wireless communications
WO2013119988A1 (en) 2012-02-10 2013-08-15 Taiwan Liposome Company, Ltd Pharmaceutical compositions to reduce complications of ocular steroid
JP5965187B2 (ja) * 2012-03-30 2016-08-03 小林製薬株式会社 油性軟膏剤
CN109985048B (zh) * 2017-12-29 2021-06-29 广州市赛普特医药科技股份有限公司 2β,3α,5α-三羟基雄甾-6-酮用于炎症反应的治疗

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3197469A (en) * 1958-08-06 1965-07-27 Pharmaceutical Res Products In 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3357974A (en) * 1965-12-28 1967-12-12 Merck & Co Inc Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
SE378109B (bg) * 1972-05-19 1975-08-18 Bofors Ab
US3796701A (en) * 1973-02-26 1974-03-12 Squibb & Sons Inc 5alpha,9-oxazino steroids and 9-carboxamido steroids
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4304727A (en) * 1980-12-05 1981-12-08 The Upjohn Company 9α-Debromination
JPS58176485A (ja) * 1982-04-08 1983-10-15 Nippon Denso Co Ltd 可変容量圧縮機
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
JPS6067496A (ja) * 1983-09-26 1985-04-17 Ota Seiyaku Kk フルオシノロン１６，１７−アセトニド２１−ブチレ−トおよびその製造法
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters

Also Published As

Publication number Publication date
DE69224982T2 (de) 1998-07-30
MY111502A (en) 2000-07-31
NO304074B1 (no) 1998-10-19
TNSN92008A1 (fr) 1993-06-08
DK0572451T3 (da) 1998-10-19
ES2114931T3 (es) 1998-06-16
KR100205835B1 (ko) 1999-07-01
BG61816B1 (bg) 1998-06-30
HU9302243D0 (en) 1993-10-28
JP2947933B2 (ja) 1999-09-13
IE920167A1 (en) 1992-08-12
US5614514A (en) 1997-03-25
PT100087A (pt) 1993-05-31
EE03110B1 (et) 1998-08-17
TW287166B (bg) 1996-10-01
NO932762L (no) 1993-08-02
CN1155418A (zh) 1997-07-30
YU6492A (sh) 1994-12-28
JPH06505233A (ja) 1994-06-16
FI933451A0 (fi) 1993-08-03
CZ149593A3 (en) 1994-03-16
PT100087B (pt) 1999-09-30
NZ241211A (en) 1993-08-26
RU2112775C1 (ru) 1998-06-10
WO1992013873A1 (en) 1992-08-20
EP0572451B1 (en) 1998-04-01
EP0572451A1 (en) 1993-12-08
CN1064078A (zh) 1992-09-02
AU661472B2 (en) 1995-07-27
DE69224982D1 (de) 1998-05-07
BG98011A (bg) 1994-04-29
HU221168B1 (en) 2002-08-28
IS1653B (is) 1997-06-20
CA2100453A1 (en) 1992-08-05
AU1235892A (en) 1992-09-07
UA43825C2 (uk) 2002-01-15
FI933451A (fi) 1993-08-03
RO111272B1 (ro) 1996-08-30
HK1004335A1 (en) 1998-11-20
NO932762D0 (no) 1993-08-02
AP365A (en) 1994-10-21
IL100542A (en) 1997-02-18
YU48893B (sh) 2002-10-18
MX9200374A (es) 1992-08-01
PL170383B1 (pl) 1996-12-31
CZ282057B6 (cs) 1997-05-14
SE9100342D0 (sv) 1991-02-04
CN1076607C (zh) 2001-12-26
SK281802B6 (sk) 2001-08-06
ATE164589T1 (de) 1998-04-15
DZ1554A1 (fr) 2002-02-17
AP9200354A0 (en) 1992-01-31
IL100542A0 (en) 1992-09-06
IS3809A (is) 1992-08-05
CN1158726A (zh) 1997-09-10
CN1076606C (zh) 2001-12-26
SK79793A3 (en) 1994-03-09
MA22407A1 (fr) 1992-10-01
CN1039329C (zh) 1998-07-29
HUT64972A (en) 1994-03-28

Similar Documents

Publication Publication Date Title
ZA92234B (en) Novel steroid esters
GR3030657T3 (en) Novel steroids
GB2257256B (en) Plastometer
ZA921840B (en) Triazinyl-substituted acrylic esters
ZA914555B (en) 2-methoximinocarboxylic esters
ZA921247B (en) Steroid formulations
GB9106569D0 (en) Starch esters
EP0531821A3 (en) 1-alkoxyhexatriene-2-carboxylic acid esters
ZA939338B (en) New steroids
GB9122328D0 (en) Novel esters
HU9401635D0 (en) Panel structure
GR3026522T3 (en) Ethyl 6-formyl-4-hexenoate
GB9304619D0 (en) Esters
GB9112683D0 (en) Screen
IL103938A0 (en) Novel phenylsulfonylacrylate ester derivatives
ZA936367B (en) Esters
GB9121278D0 (en) Ester
GB9221636D0 (en) Esters
GB9221512D0 (en) Phenylpyrazine esters
ZA907896B (en) Substituted acrylamido-penicillanic esters
GB2258256B (en) Improved structural panel
GB9105170D0 (en) Panel
AU114582S (en) Panel
GB9224880D0 (en) Steroids
ZA935131B (en) 17-Spiromethylene steroids